8-K: Darling Ingredients and Tessenderlo Group to Form $1.5 Billion Collagen Joint Venture, Nextida

Darling Ingredients and Tessenderlo Group have signed a non-binding term sheet to combine their collagen and gelatin businesses into a new joint venture named Nextida, creating a company with approximately $1.5 billion in annual revenue.

Summary

• Darling Ingredients and Tessenderlo Group have agreed to form a joint venture called Nextida, combining their collagen and gelatin businesses.
• Darling Ingredients will hold an 85% ownership stake, while Tessenderlo Group will hold the remaining 15%.
• Nextida is expected to generate approximately $1.5 billion in annual revenue.
• The joint venture will have a total gelatin and collagen capacity of about 200,000 metric tons across 23 facilities.
• The transaction is expected to close in 2026, pending regulatory approvals and customary closing conditions.
• The deal is a non-cash transaction, combining assets and capabilities of both companies.
• Nextida aims to capitalize on the fast-growing collagen-based health, wellness, and nutrition sector.

Sentiment

Score: 8

Explanation: The announcement is positive due to the strategic combination of assets, the potential for growth in a high-demand sector, and the clear benefits outlined by management. The non-cash nature of the transaction and the expected synergies further contribute to a favorable outlook.

Positives

• The joint venture creates a top-tier company in the fast-growing collagen-based health, wellness, and nutrition sector.
• Nextida is expected to generate approximately $1.5 billion in annual revenue.
• The combination provides expanded infrastructure and geographical reach.
• The deal is expected to create new opportunities for growth and enhance shareholder value.
• The joint venture will benefit from shared technology expertise and a complementary offering for a global customer base.
• The integration minimizes the need for additional infrastructure investment while realizing significant synergies.

Negatives

• The transaction is subject to customary due diligence, negotiation of definitive transaction documents, satisfaction of customary closing conditions, and regulatory approvals, which could delay or prevent the deal from closing.
• The term sheet is non-binding, meaning the final terms could change or the deal could fall apart.
• The companies must successfully integrate their operations to realize the anticipated synergies and benefits.

Risks

• The formation of the joint venture is subject to regulatory approvals, which may not be obtained.
• The companies may not be able to successfully negotiate definitive transaction documents.
• The anticipated benefits of the proposed transaction may not be realized.
• There are risks and uncertainties that could cause actual results to differ materially from forward-looking statements.
• Global demands for grain and oilseed commodities, which have exhibited volatility, and can impact the cost of feed for cattle, hogs and poultry, thus affecting available rendering feedstock and selling prices for the Company's products.

Future Outlook

The joint venture is expected to create new opportunities for growth and enhance shareholder value by capitalizing on the fast-growing collagen-based health, wellness, and nutrition sector.

Management Comments

• Randall C. Stuewe, Chairman and Chief Executive Officer of Darling Ingredients, stated that the joint venture provides a strong platform for accelerated product development and growth.
• Luc Tack, Chief Executive Officer of Tessenderlo Group, added that the combination will allow them to benefit from each other by sharing technology expertise and providing a complementary offering for their global customer base.

Industry Context

The announcement reflects a growing trend in the food and nutrition industry towards specialized ingredients and health-focused products, with companies seeking to consolidate their positions in high-growth sectors like collagen.

Comparison to Industry Standards

• The combined entity, Nextida, aims to compete with established players in the collagen and gelatin market, such as Gelita and Nitta Gelatin.
• The $1.5 billion revenue target positions Nextida as a significant player, potentially rivalling the market share of leading competitors.
• The 200,000 metric tons capacity indicates a substantial production capability, comparable to major global producers.

Stakeholder Impact

• Shareholders of Darling Ingredients and Tessenderlo Group can expect potential value creation through growth and synergies.
• Employees of Rousselot and PB Leiner may experience changes as the businesses are integrated.
• Customers will have access to a broader range of collagen and gelatin products.
• Suppliers may see increased demand for raw materials.
• Creditors may see improved financial stability due to the combined entity's stronger market position.

Next Steps

• Finalizing agreement terms and negotiating definitive transaction documents.
• Obtaining regulatory approvals.
• Closing the transaction, expected in 2026.
• Integrating the Rousselot and PB Leiner businesses into Nextida.
• Developing and launching new collagen-based products.

Key Dates

Keywords

Nextida, collagen, gelatin, joint venture, Darling Ingredients, Tessenderlo Group, health, wellness, nutrition